OQROGet OQRO Pro
Insider trade

Whitehawk Therapeutics (WHWK)CFO sold ~$297K

Scott M. Giacobello, CFO at Whitehawk Therapeutics, sold ~$297K of Whitehawk Therapeutics shares.

~$297K
Approx. value · 77K sh @ $3.86
437K
Holds after · shares reported
Traded
Apr 15, 2026
Filed
Apr 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 2, 2026Insider · 3 peopleInsiders: 3 sales (~$32K)
  2. Mar 12, 2026Company filing · Form 8-K · ResultsReported its results
  3. Apr 2, 2026InsiderCEO sold ~$93K of WHWK shares in the open market
  4. Apr 6, 2026InsiderCEO sold ~$359K of WHWK shares in the open market
  5. Apr 7, 2026InsiderCEO sold ~$323K of WHWK shares in the open market
  6. Apr 8, 2026InsiderCEO sold ~$217K of WHWK shares in the open market
  7. Apr 9, 2026Insider · 2 peopleInsiders: 2 sales (~$228K)
  8. Apr 10, 2026InsiderOfficer sold ~$23K of WHWK shares in the open market
  9. Apr 13, 2026InsiderOfficer sold ~$91K of WHWK shares in the open market
  10. Apr 14, 2026InsiderOfficer sold ~$337K of WHWK shares in the open market
  11. Apr 15, 2026 · this disclosureInsiderCFO sold ~$297K of WHWK shares in the open market

What came next

  1. Apr 16, 2026InsiderCFO sold ~$585K of WHWK shares in the open market
  2. May 7, 2026Company filing · Form 8-K · ResultsReported its results
  3. May 12, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
  4. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Whitehawk Therapeutics

For Whitehawk Therapeutics, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its WHWK page.

Other recent filings by Scott M. Giacobello, CHIEF FINANCIAL OFFICER

The full history of Scott M. Giacobello, CHIEF FINANCIAL OFFICER is on the profile page.

How this filing works

Other disclosures at Whitehawk Therapeutics

Everything OQRO holds on this company is on its WHWK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data